District court rules federal limits to vaccines not based on science, NYT says

Bostong U.S. District Judge Brian Murphy on Monday has sided with medical groups who argued that HHS Secretary Kennedy and the agencies he oversees have unlawfully altered federal policies, which will result in an increase for barriers to getting vaccinated, New York Times reports. The ruling suggests that the federal government had not based its decisions on science in limiting the shots. Publicly traded companies that could be impacted include Moderna (MRNA), Pfizer (PFE), BioNTech (BNTX), Novavax (NVAX), AstraZeneca (AZN), Bristol Myers (BMY), Eli Lilly (LLY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY), and Sanofi (SNY).